← Leaderboards
Huston Davis Adkisson
Stream Biomedical, Inc.
$3,440,793
Attributed
$3,440,793
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$3,440,793 · 2
By mechanism
R44$3,047,496 · 1
R43$393,297 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Lynn Briscoe · Leidos Biomedical Research, Inc.$110,540,429
- Ted Ross · University Of Georgia$68,763,143
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$57,713,529
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Research focus
Pre-ClinicalStreamFunctional OutcomesPost StrokeProteoglycanRodentBrainElderlyOutcome MeasurePerlecanProtein FragmentProteinsQuality Of LifeRecombinantsAcuteAnimalsBiological Response Modifier TherapyDoseIn VitroMouse ModelAstrogliosisBaseBasement MembraneStrenuous Exercise
Grant awards (4)
Selection & Optimization of a Therapeutic Protein for Acute Ischemic Stroke Functional Recovery$700,571
R44 · FY2021 · NS · contact PI
Selection & Optimization of a Therapeutic Protein for Acute Ischemic Stroke Functional Recovery$1,579,337
R44 · FY2020 · NS · contact PI
Selection & Optimization of a Therapeutic Protein for Acute Ischemic Stroke Functional Recovery$767,588
R44 · FY2019 · NS · contact PI
in vitro and in vivo Assessments of Novel Protein Therapy for Disease Modification in Alzheimer's Mice$393,297
R43 · FY2019 · AG · contact PI